Founders Longevity Forum Singapore 2025: A Preview of Innovation
On February 27-28, 2025, Singapore will host the much-anticipated Founders Longevity Forum, an event dedicated to advancing the fields of healthspan, lifespan, and longevity science. Over two dynamic days, thought leaders, researchers, and investors will converge to explore groundbreaking innovations, investment opportunities, and real-world applications that aim to revolutionize healthy aging.
This collaborative effort between Founders Forum, the National University of Singapore (NUS), and Longevity.Technology promises a mix of thought-provoking keynotes, engaging panels, and specialized tracks, all designed to cater to diverse interests.
Day One: Setting the Stage for Longevity Breakthroughs
The first day begins with plenary sessions addressing the transformative potential of longevity science for societal and economic change. Attendees will gain valuable insights into scientific advances and market opportunities shaping this burgeoning field. 
Keynotes to Watch
- Longevity for Economic and Social Change: This opening keynote will explore how breakthroughs in longevity are reshaping societal structures and global economies.
- The Realization of Prevention: Professor Andrea Maier, Co-Director of the NUS Healthy Longevity Academy, will discuss how preventative strategies can transform health outcomes.
Morning Panels
- Introduction to the Longevity Universe: Dr. David Dodick, Chief Science and Medical Officer at Atria, will outline the state of longevity science and its future directions.
- Longevity Investment Landscape: Phil Newman, CEO of Longevity.Technology, will reveal trends and funding opportunities driving the longevity sector.
- Consumer Longevity Trends: Luc Aguilar from L’Oréal will share insights into emerging opportunities in the consumer-focused longevity market.
Afternoon Specialized Tracks
Attendees can tailor their experience by choosing between two focused tracks: Precision Geromedicine and Longevity Investment.
Precision Geromedicine Track
- Biomarkers of Aging: Dane Gobel, Executive Director of the Biomarkers of Aging Consortium, will present advancements in aging clocks and their applications.
- Aging Blood Clocks: Professor Jan Gruber from Yale-NUS College will share insights into how blood biomarkers can predict aging trajectories.
- Diagnostics Panel Discussion: Experts including Dr. Jeremy Lim (Ameli) and Vishal Harnal (500 Global) will explore the future of diagnostics in extending healthspan.
Longevity Investment Track
- Consumer Diagnostics for Longevity and Healthspan: Industry leaders, including Hannah Went (TruDiagnostic) and Dr. Elvin Siew (Emagene.Life), will discuss how consumer-driven diagnostics are revolutionizing health management.
- Wellness and Gym Sectors Embracing Longevity: Todd Crane (Technogym) will explain how the fitness industry is integrating longevity strategies into wellness initiatives.
- Longevity Clinics: Experts such as Dr. Nicole Sirotin (Institute for Healthier Living Abu Dhabi) and Avi Roy (Founders Health) will highlight the rise of innovative longevity clinics.
Day Two: Translating Science into Real-World Impact
The second day builds on the momentum with additional keynotes, panels, and interactive sessions aimed at applying scientific discoveries to practical health solutions.
Precision Geromedicine Track
- Nutrition and Women’s Health Across Generations: Professor Cuilin Zhang will address the importance of nutrition in women’s health throughout life stages.
- Brain Aging and Mitochondrial Health: Siobhan Mitchell (MitoQ) will discuss mitochondrial-focused strategies to prevent brain aging.
- Integrating Geromedicine into Healthcare: Professor Mark Kramer (VU University Amsterdam) will examine ways to embed geromedicine into current healthcare systems.
Longevity Investment Track
- Aging Science Meets Market Need: David Gobel (Methuselah Foundation) will highlight how advancements in aging science align with market demands.
- Investing in Preclinical Longevity Therapies: Gobel will join Petr Sramek (Longevity.Tech Fund) to explore the investment potential of preclinical therapies.
- AI in Drug Discovery: Frank Pun (Insilico Hong Kong) will demonstrate how artificial intelligence is revolutionizing drug development for longevity.
Closing Sessions
The forum will conclude with wrap-up discussions for each track, offering actionable insights and collaborative opportunities to drive future advancements.
